Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Aug
19
2019
EPA Announces FIFRA SAP Public Meeting to Consider Approaches for Incorporating Surface Water Monitoring Data in Pesticide Risk Assessments and Requests Nominations of Ad hoc Expert Reviewers Bergeson & Campbell, P.C.
Sep
27
2019
ECHA Will Hold November Webinar on Updated REACH Information Requirements for Nanoforms Bergeson & Campbell, P.C.
Oct
10
2019
EPA Updates Aquatic Life Benchmarks for Several Pesticides Bergeson & Campbell, P.C.
May
10
2023
JRC Publishes Guidance Document on Implementation of the EC’s Revised Definition of Nanomaterials, Launches Free Course on Nanomaterials in EU Legislation Bergeson & Campbell, P.C.
Feb
10
2020
EPA Will Host Conference Call on TSCA Fees Obligations Bergeson & Campbell, P.C.
Feb
13
2020
NIA Publishes Position Paper on Terminology of “Nanoplastics” Bergeson & Campbell, P.C.
Jun
21
2023
MDEP Updates PFAS in Products FAQs Bergeson & Campbell, P.C.
Mar
25
2016
Solazyme Becomes TerraVia, Shifts Focus To Food And Specialty Ingredients Bergeson & Campbell, P.C.
Mar
11
2020
EPA Announces Latest Update to TSCA Inventory Bergeson & Campbell, P.C.
May
4
2016
NNCO Accepting Registrations for SME and NanoEHS Webinars Bergeson & Campbell, P.C.
Aug
17
2023
ICIS Innovation Awards Recognize Sustainability in Chemical Industry Bergeson & Campbell, P.C.
Apr
17
2020
EC Launches Initiative Aimed At Connecting Stakeholders With Biobased Compounds Bergeson & Campbell, P.C.
Sep
9
2016
Buyer Beware—That Mosquito Repellent May Not Have Been Tested For Efficacy Bergeson & Campbell, P.C.
Nov
14
2023
USDA, EPA, and FDA Post Report on Stakeholder Comments on Coordinated Framework for the Regulation of Biotechnology and Plain-Language Regulatory Information Bergeson & Campbell, P.C.
Jun
7
2020
Ninth Circuit Vacates EPA’s Renewal of Conditional Registrations for Lower Volatility Dicamba Formulations Bergeson & Campbell, P.C.
Dec
14
2023
ECHA Calls for Evidence on Certain Chromium (VI) Substances Bergeson & Campbell, P.C.
Dec
29
2023
OSTP Publishes Report on Vision, Needs, and Proposed Actions for Data for the Bioeconomy Initiative Bergeson & Campbell, P.C.
Jul
7
2020
EPA NAM Work Plan to Reduce Use of Animals in Chemical Testing Bergeson & Campbell, P.C.
Jul
10
2020
Industry Associations Petition EPA to Develop Risk Management Procedural Rule under TSCA Section 6 Bergeson & Campbell, P.C.
Aug
7
2020
U.S. Senate Passes The Sustainable Chemistry Research And Development Act Bergeson & Campbell, P.C.
Jan
27
2017
EPA Delays Effective Date of 2017 RFS Requirements Bergeson & Campbell, P.C.
Mar
1
2017
Report Claims OECD Dossiers on Nanomaterials Are of “Little to No Value” Bergeson & Campbell, P.C.
Nov
6
2020
USDA Announces Grants To Increase Ethanol And Biodiesel Sales Bergeson & Campbell, P.C.
Nov
12
2020
EPA Proposes Revised Crop Groups for Herbs and Spices Bergeson & Campbell, P.C.
May
10
2017
EPA Will Delay Effective Date of TSCA Section 8(a) Rule Concerning Nanoscale Materials Bergeson & Campbell, P.C.
Jun
13
2017
ECHA Committee Concludes Titanium Dioxide Should Be Classified as Suspected of Causing Cancer When Inhaled Bergeson & Campbell, P.C.
Feb
3
2021
EPA Announces the Issuance of a Revised Advisory on Disinfectants Making False and Misleading Claims against COVID-19 Bergeson & Campbell, P.C.
Apr
13
2021
EC Committee Concludes Hydroxyapatite (Nano) in Cosmetic Products Can Pose a Risk to Consumers Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins